Who
Chin Hyok Lee
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Lycia Therapeutics; Chief Medical Officer, Allakos.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 Feb 2024
- Last trade
- 11 Aug 2026
- Last filed
- 26 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Aug 2026filed 26 Oct 2026 | LYCA Lycia Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —73,191 at $0.00 | filing |
| 4 Dec 2024filed 6 Dec 2024 | Allakos | SEC FORM 4 Code F | $12K10,634 at $1.13 | filing |
| 9 Sep 2024filed 11 Sep 2024 | Allakos | SEC FORM 4 Code F | $29K45,320 at $0.65 | filing |
| 16 Feb 2024filed 21 Feb 2024 | Allakosoption or derivative | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.